OMsignal, developer of a revolutionary line of bio-sensing clothing, has secured seed round financing of $1M from venture capital funds Real Ventures, Golden Venture Partners, and David Cohen (CEO of TechStars). The company was formed around the idea that clothing could help consumers be healthier, fitter and happier.
With the recent rise in popularity of bracelets and clip-ons, consumers have demonstrated a clear demand for wearable computing and all the bio-feedback that comes along with it. In addition to physical activity, bio-sensing clothing from OMsignal captures ECG and breathing patterns on a continuous basis.
"OMsignal goes well beyond today's existing smart accessories to track core biological signals," said Matt Golden, Golden Venture Partners. "This represents a major shift in the ability to monitor in-depth biological rhythms discretely and continuously as people go about their normal lives."
Alan MacIntosh, from Real Ventures noted, "The founders of OMsignal pulled together an exceptionally talented team from very diverse and highly specialized fields including scientists, designers, engineers, medical experts as well as renowned academic researchers. Working with world-class partners, OMsignal has also tapped into Montreal's unique history of high-end textile development and its vibrant tech startup community."
This summer, the company will open its bio-sensing apparel platform to external parties. Stéphane Marceau, CEO of OMsignal explains, "Our ultimate goal is to enable a variety of partner services and applications to help people lead healthier and happier lives. In line with this goal and to encourage innovation on our platform, we've initiated a program to give 100 free shirts to innovators of all types".
About OMsignal
OMsignal has developed a revolutionary line of bio-sensing clothing that connect seamlessly with mobile devices.
OMsignal garments are designed for everyday wear, to compliment life without getting in the way of daily life. Physiological signals acquired from the body are filtered and interpreted to deliver useful information and actionable insights to consumers, health and medical practitioners, and to researchers in a variety of human related fields of research.
